Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Acti
-
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
-
Didn’t Catch Cardano and Binance Coin? BNB News Signals You Could Miss Out Again, APEMARS Presale Set to Be One of the Top Crypto Coins in 2026
-
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
-
Best Gamification Solutions for iGaming Operators and Mid-Size Platform Providers
-
Amazon Growth Lab Launches Creative Cascade for Rufus-Ready Amazon PDP Modernization
-
Firma.dev Launches Firma 12 With Full AI Integration, Becoming the First E-Signature Platform You Can Operate Entirely Through AI
-
Dual Imaging Identifies Cause of Heart Attack in Patients Without Blocked Arteries
-
Brazil Plant-Based Dairy Market to Reach USD 215 Million by 2032 Amid Rising Demand for Dairy Alternatives and Expanding Retail Presence| Vyansa Intelligence
-
Team Clermont and Classic City Rotary Announce the 2026 10th Annual Vic Chesnutt Songwriter of the Year Awards April 23, 8:00p.m., Morton Theatre, Athens, Georgia.
-
Decision of the US District Court for the Southern District of New York in the TriZetto re-trial
-
allocatte Redefines Real Estate Investing With Blockchain-Powered Fractional Ownership Platform
-
Market Synergy Group Announces the Addition of Carrie Freeburg as Partner
-
Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy fo
-
Louisiana DWI Law Resource Center Expanded by Barkemeyer Law Firm
-
Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting
-
Mulvihill Enhanced Split Preferred Share ETF Announces Year End Results
-
Premium Global Income Split Corp. Announces Year End Results
-
Mulvihill Premium Yield Fund Announces Year End Results
-
PureHealth Research reports Why Targeted Supplements for Hearing Loss May Be Your Ears' Best Defense
-
Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results
-
US Dealer Licensing (or USDL) Announces Strategic Investment by Tradepost Partners
-
New Novel Salt and Stone Reveals the Hidden Price of Power Within a New Orleans Dynasty
-
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
-
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
-
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
-
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
-
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
-
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
-
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
-
London AI Startup Coda One Launches Free Platform With 59 Productivity Tools, Taking Aim at Subscription Fatigue
-
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
-
HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
-
CODE27 Secures Over $10 Million in Funding to Build Immersive Interactive Character Companion Hardware
-
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Sess
-
BlueKong Networks unveils BlueKong Go — an On-Demand Platform set to transform IT Field Services
-
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
-
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
-
Record Your Passion: TORRAS Partners with Portugal Football for the Season Ahead
-
McLaren Driver Tommy Pintos Partners With Priority Tire for 2026 Season
-
ADVAN ADVERTISING INC. (ADVAPP) Accelerates Global Expansion
-
TitanPlay Focuses on Player Protection Through Culturally Aware Responsible Gambling Measures
-
TxFlow L1 Mainnet Launch Marks a New Phase for Multi-Application On-Chain Finance
-
University of Phoenix White Paper Translates "Sandwich Generation" Research into Employer Strategies to Improve Retention and Workforce Stability
-
Redefining New Energy: iCAUR’s System Approach to Modern Mobility
-
MAC Surfaces Announces Sports Surfacing Across 3 States
-
Johanna Gonzalez Announces TRUE 4G Method
-
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
-
Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026™ Host City in the U.S.
-
Searchless.ai Launches as the First Publication Dedicated to Covering the End of Traditional Search

